secwatch.observer — SEC 8-K summary
======================================

Issuer:     NN INC (NNBR)
CIK:        0000918541
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0000918541-23-000136
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NN Inc. Q3 adj EBITDA up to $14.5M (11.6% of sales); raises 2023 FCF guidance to $10-14M
--------------------------------------------------------------------------------

- Net sales $124.4M (-2.2% YoY); operating loss $2.7M; net loss $5.1M vs $2.2M prior year.
- Adjusted EBITDA $14.5M (11.6% margin) vs $11.8M (9.3%) YoY; free cash flow generation of $11.3M.
- Leverage ratio improved to 3.37x from 3.87x sequentially; launched NN Medical division.
- Full-year 2023 outlook: revenue $487-497M; adj EBITDA $40-44M; FCF raised to $10-14M.
- New COO and CPO added; cost productivity programs expected to yield ~$10M adj EBITDA improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/918541/000091854123000136/0000918541-23-000136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/918541/000091854123000136/nnbr-20231106.htm
  HTML page:      https://secwatch.observer/filing/0000918541-23-000136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer